Spyre Therapeutics Inc. (SYRE) Company Profile & Statistics

Spyre Therapeutics Inc.
SYRE
(Nasdaq - US)
Closed
32.55
-1.61 (-4.71%)
in:usd•As of: Oct 31, 2024 15:59 UTC -4
Open
34.20
High
34.20
Low
32.22

About Spyre Therapeutics Inc.

CEO

Cameron Turtle

Headquarters

221 crescent street,building 23, suite 105

waltham, ma 02453, united states

Auditor

PricewaterhouseCoopers LLP

Employees

Share Holders

Website

https://www.spyre.com

Industry

biotechnology

Sector

health technology

Company Overview

Spyre Therapeutics is a biotechnology company which aims to create inflammatory bowel disease products by combining antibody engineering, rational therapeutic combinations and precision medicine approaches for patient selection. Spyre Therapeutics, formerly known as Aeglea BioTherapeutics Inc., is based in WALTHAM, Mass.

Spyre Therapeutics Inc. Statistics

Valuation Measures

Market Capitalization ²	1.66B
Enterprise Value	1.61B
Enterprise Value/EBITDA (ttm)	-10.17
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.23
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-57.17%
Return on Assets (ttm)	-36.10%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-158.49M
Net Income Avi to Common (ttm)	-185.98M
Diluted EPS (ttm)	-15.45

Share Statistics

Beta (5Y Monthly)	2.92
52-Week Change	184.78%
S&P500 52-Week Change	34.63%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	50.79M
Dividend Yield	0.00%
Float ⁴	47.76M
% Held by Insiders	6.20%
% Held by Institutions	80.39%

Balance Sheet

Total Cash (mrq)	426.00M
Total Cash Per Share (mrq)	8.39
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	19.70%
Quick Ratio (mrq)	19.70%
Book Value Per Share (mrq)	7.37

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.00
Free Cash Flow (ytd)	-90.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Spyre Therapeutics Inc.

Trade With A Regulated Broker